TY - JOUR
T1 - Constitutional de novo and postzygotic mutations in isolated cases of cerebral cavernous malformations
AU - Rath, Matthias
AU - Spiegler, Stefanie
AU - Nath, Neetika
AU - Schwefel, Konrad
AU - Di Donato, Nataliya
AU - Gerber, Johannes
AU - Korenke, G. Christoph
AU - Hellenbroich, Yorck
AU - Hehr, Ute
AU - Gross, Stephanie
AU - Sure, Ulrich
AU - Zoll, Barbara
AU - Gilberg, Eberhard
AU - Kaderali, Lars
AU - Felbor, Ute
PY - 2017
Y1 - 2017
N2 - Background: Cerebral cavernous malformations (CCM) are vascular lesions of the central nervous system that can be found in sporadic or autosomal dominantly inherited forms and manifest with headaches, seizures, and hemorrhagic stroke. The precise proportion of de novo mutations in the CCM1, CCM2, and CCM3 genes remains unknown. Methods: We here present a series of six trios with de novo mutations that have been analyzed by amplicon deep sequencing to differentiate between constitutional and postzygotic mutations. Results: In one case, allelic ratios clearly indicated mosaicism for a CCM3 splice site mutation found in blood and buccal mucosa of a 2-year-old boy with multiple CCMs. The remaining five de novo mutations proved to be constitutional. In addition to three CCM3, two CCM1, and one CCM2 de novo point mutations, a deletion of the entire CCM3 gene was identified in an index case that most likely originated from an early postzygotic event. These are the first high-level mosaic mutations reported in blood samples of isolated CCM cases. Conclusion: Our data demonstrate that de novo mutations in CCM1-3 might be more frequent than previously thought. Furthermore, amplicon deep sequencing is useful to discriminate between patients with constitutional and postzygotic mutations, and thereby improves genetic counseling.
AB - Background: Cerebral cavernous malformations (CCM) are vascular lesions of the central nervous system that can be found in sporadic or autosomal dominantly inherited forms and manifest with headaches, seizures, and hemorrhagic stroke. The precise proportion of de novo mutations in the CCM1, CCM2, and CCM3 genes remains unknown. Methods: We here present a series of six trios with de novo mutations that have been analyzed by amplicon deep sequencing to differentiate between constitutional and postzygotic mutations. Results: In one case, allelic ratios clearly indicated mosaicism for a CCM3 splice site mutation found in blood and buccal mucosa of a 2-year-old boy with multiple CCMs. The remaining five de novo mutations proved to be constitutional. In addition to three CCM3, two CCM1, and one CCM2 de novo point mutations, a deletion of the entire CCM3 gene was identified in an index case that most likely originated from an early postzygotic event. These are the first high-level mosaic mutations reported in blood samples of isolated CCM cases. Conclusion: Our data demonstrate that de novo mutations in CCM1-3 might be more frequent than previously thought. Furthermore, amplicon deep sequencing is useful to discriminate between patients with constitutional and postzygotic mutations, and thereby improves genetic counseling.
UR - http://www.scopus.com/inward/record.url?scp=85041377039&partnerID=8YFLogxK
U2 - 10.1002/mgg3.256
DO - 10.1002/mgg3.256
M3 - Journal articles
AN - SCOPUS:85041377039
SN - 2324-9269
VL - 5
SP - 21
EP - 27
JO - Molecular Genetics and Genomic Medicine
JF - Molecular Genetics and Genomic Medicine
IS - 1
ER -